The FDA has recently approved riluzole as the first drug to prolong the survival of patients with this disease, and researchers have found that the mutations A261del and AG1548del in a second gene result in this affliction.
The FDA has recently approved riluzole as the first drug to prolong the survival of patients with this disease, and researchers have found that the mutations A261del and AG1548del in a second gene result in this affliction. It results from the SOD1 mutation in the gene 2CR6, which codes for the 184 kilodalton protein alsin that regulates microtuble assembly. The dysfunction of this protein results in the inability to maintain cell structure, causing the degeneration of motor neurons throughout the nervous system. FTP, identify this progressively degenerative neuron disease that afflicts Stephen Hawking, also known as Lou Gehrig's disease.
The FDA has recently approved riluzole as the first drug to prolong the survival of patients with this disease, and researchers have found that the mutations A261del and AG1548del in a second gene result in this affliction.
{ALS} or {amyotrophic lateral sclerosis} (accept {Lou Gehrig’s} disease on early buzz)